0B68 Cristofanilli, Massimo - Thomas Jefferson University - Thomas Jefferson University

Massimo Cristofanilli, MD

Contact Dr. Cristofanilli

925 Chestnut Street
Suite 320A
Philadelphia, PA 19107

(215) 955-8874

Most Recent Peer-reviewed Publications

  1. TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients
  2. Erythropoiesis stimulating agents and clinical outcomes of invasive breast cancer patients receiving cytotoxic chemotherapy
  3. Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor-positive breast cancer
  4. Inflammatory Breast Cancer Management in the National Comprehensive Cancer Network: The Disease, Recurrence Pattern, and Outcome
  5. Gene expression profiles of inflammatory breast cancer: Co 18B9 rrelation with response to neoadjuvant chemotherapy and metastasis-free survival
  6. Circulating tumour cells: Telling the truth about metastasis
  7. Antitumor response of an ERBB2 amplified inflammatory breast carcinoma with EGFR mutation to the EGFR-TKI erlotinib
  8. A comparison of epidemiology, biology, and prognosis of inflammatory breast cancer in Japanese and US populations
  9. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition
  10. Presence of anaplastic lymphoma kinase in inflammatory breast cancer
  11. The Third International Inflammatory Breast Cancer Conference
  12. Circulating tumor cells predict progression-free and overall survival in Chinese patients with metastatic breast cancer, HER2-positive or triple-negative (CBCSG004): A multicenter, double-blind, prospective trial
  13. EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells
  14. Phase I-II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinoma
  15. Clinical relevance of cancer stem cells in bone marrow of early breast cancer patients
  16. Uncovering the molecular secrets of inflammatory breast cancer biology: An integrated analysis of three distinct affymetrix gene expression datasets
  17. Circulating tumor cells in metastatic colorectal cancer: Do we need an alternative cutoff?
  18. Circulating tumor DNA to monitor metastatic breast cancer [5]
  19. Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer
  20. Inflammatory breast cancer (IBC): Clues for targeted therapies